Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2 [clinicaltrials:NCT00033956]
Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2 [clinicaltrials:NCT00033956]
Bio2RDF identifier
NCT00033956
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00033956
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The clinical use of IL- ...... receiving IL-2 therapy.
brief title [clinicaltrials_vocabulary:brief-title]
Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
High-dose interleukin-2 ...... 48 patients will be studied.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2002-04-17T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
Hypotension
Interleukin-2
Metastatic Melanoma
Renal Cell Carcinoma
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2005-06-23T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00033956
official title [clinicaltrials_vocabulary:official-title]
Phase I/II Open Label Dose Esc ...... anoma or Renal Cell Carcinoma.
org study id [clinicaltrials_vocabulary:org-study-id]
U10-01-12-002
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2001-12-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2002-05-01T00:00:00Z
identifier
clinicaltrials:NCT00033956
title
Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2
@en
type
label
Evaluation of M40403 for the P ...... 2 [clinicaltrials:NCT00033956]
@en